Astex Pharmaceuticals, Inc.

299 articles with Astex Pharmaceuticals, Inc.

• Astex Pharmaceuticals Responds to Further Misleading Claims Made by Sarissa Capital

  10/10/2013

• Astex Pharmaceuticals Announces Expiration of HSR Waiting Period for Pending Transaction

  10/7/2013

• Astex Pharmaceuticals Shareholder Opposes $886 Million Bid by Otsuka Pharmaceutical Co., Ltd.

  10/3/2013

• Astex Pharmaceuticals Announces Oral Presentation of SGI-110 AML Data at the European Cancer Congress

  9/30/2013

• Japan's Otsuka Pharmaceutical Co., Ltd. Shells Out $886 Million for U.S. Cancer Firm Astex Pharmaceuticals

  9/5/2013

• Astex Pharmaceuticals to Present at Investor Conferences in September

  9/3/2013

• Astex Pharmaceuticals Sees Positive Results From SGI-110 AML Phase 2 Study; Stock Rockets +24.45% at Market Close (August 28, 2013)

  8/28/2013

• Astex Pharmaceuticals Reports 2013 Second Quarter Financial Results

  8/1/2013

• Astex Pharmaceuticals to Announce 2013 Second Quarter Financial Results on August 1st

  7/29/2013

• Astex Pharmaceuticals Announces First Data Showing Early Combination Treatment of HSP90 Inhibitor AT13387 With Targeted Agents Delays Emergence of Resistance in Preclinical Models

  7/22/2013

• Astex Pharmaceuticals Announces IND Candidate: ASTX727 a Potential Best-in-Class Oral Hypomethylator

  7/8/2013

• Astex Pharmaceuticals to Present at JMP Securities Healthcare Conference

  7/3/2013

• Astex Pharmaceuticals Announces Oral Presentation of SGI-110 Data at the Upcoming European Cancer Congress (ECCO-ESMO-ESTRO)

  6/20/2013

• Astex Pharmaceuticals to Present at Jefferies and Co. Global Healthcare Conference

  5/29/2013

• Astex Pharmaceuticals to Present at UBS Global Healthcare Conference

  5/14/2013

• Astex Pharmaceuticals to Present at Needham Healthcare Conference

  4/23/2013

• Astex Pharmaceuticals to Present at ROTH Conference

  3/12/2013

• Astex Pharmaceuticals Release: Cancer Research Technology and Cancer Research UK Cambridge Research Institute Initiate AT13148 Clinical Trial to Treat Several Cancer Types

  1/17/2013

• Astex Pharmaceuticals to Present at Biotech Showcase 2013

  1/3/2013

• Astex Pharmaceuticals Announces Initiation of SGI-110 Phase 2 Trial in Advanced Hepatocellular Carcinoma (HCC) Patients

  1/2/2013